Release Date: 28/03/17 08:26 Summary: Becoming a substantial holder from RSG Price Sensitive: No Download Document 210.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%